NEW YORK (AP) — An experimental drug for one of the most difficult-to-treat types of hepatitis C has been approved by the Food and Drug Administration, adding to the surge of new options for patients with the liver-destroying virus.
National/International Headline List General Wire, San Antonio Express-News: World
Fri, 07/24/2015 - 12:46pm
NEW YORK (AP) — An experimental drug for one of the most difficult-to-treat types of hepatitis C has been approved by the Food and Drug Administration, adding to the surge of new options for patients with the liver-destroying virus.